University of Siena   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Siena Italy (1240)

Organization Overview

First Clinical Trial
2006
NCT00609401
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Azienda Ospedaliera Universitaria Senese, Siena (Italy) | Center for Immuno-Oncology, University Hospital of Siena | Department of Internal Medicine, Cardiology Unit, Le Scotte Hospital, Siena | Immunologia Oncologica - Ospedale Le Scotte Siena | Le Scotte Hospital, Siena | Medical Oncology and Immunotherapy Division, Univeristy Hospital os Siena, Siena, Italy | Medical Oncology and Immunotherapy Unit, University Hospital of Siena | Medical Oncology and Immunotherapy Unit, University Hospital of Siena, Italy | Medical Oncology and Immunotherapy, University Hospital of Siena, Italy | Ospedale Le Scotte | Ospedale Le Scotte Siena | Siena University | Siena University Hospital | University of Siena